1. Home
  2. AXSM vs TX Comparison

AXSM vs TX Comparison

Compare AXSM & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • TX
  • Stock Information
  • Founded
  • AXSM 2012
  • TX 1961
  • Country
  • AXSM United States
  • TX Luxembourg
  • Employees
  • AXSM N/A
  • TX N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • TX Steel/Iron Ore
  • Sector
  • AXSM Health Care
  • TX Industrials
  • Exchange
  • AXSM Nasdaq
  • TX Nasdaq
  • Market Cap
  • AXSM 5.1B
  • TX 5.9B
  • IPO Year
  • AXSM 2015
  • TX 2006
  • Fundamental
  • Price
  • AXSM $110.12
  • TX $31.23
  • Analyst Decision
  • AXSM Strong Buy
  • TX Buy
  • Analyst Count
  • AXSM 17
  • TX 2
  • Target Price
  • AXSM $171.65
  • TX $33.50
  • AVG Volume (30 Days)
  • AXSM 672.7K
  • TX 228.7K
  • Earning Date
  • AXSM 08-04-2025
  • TX 07-29-2025
  • Dividend Yield
  • AXSM N/A
  • TX 8.63%
  • EPS Growth
  • AXSM N/A
  • TX N/A
  • EPS
  • AXSM N/A
  • TX N/A
  • Revenue
  • AXSM $432,157,000.00
  • TX $16,803,571,000.00
  • Revenue This Year
  • AXSM $62.57
  • TX N/A
  • Revenue Next Year
  • AXSM $59.96
  • TX $6.29
  • P/E Ratio
  • AXSM N/A
  • TX N/A
  • Revenue Growth
  • AXSM 72.16
  • TX N/A
  • 52 Week Low
  • AXSM $72.21
  • TX $24.00
  • 52 Week High
  • AXSM $139.13
  • TX $37.98
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 56.52
  • TX 54.55
  • Support Level
  • AXSM $108.48
  • TX $31.54
  • Resistance Level
  • AXSM $114.66
  • TX $32.73
  • Average True Range (ATR)
  • AXSM 3.47
  • TX 0.82
  • MACD
  • AXSM 0.87
  • TX -0.01
  • Stochastic Oscillator
  • AXSM 64.95
  • TX 53.99

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.

Share on Social Networks: